Philips is on the verge of developing a new ultrasound-based drug delivery technology that will surely help people suffering from various types of cancers. The company is planning to introduce micro bubbles which contain drugs that treat cancerous growths. They can be tracked with the help of an ultrasound and later allowed to release the drugs the micro bubbles contain. This would help reduce the effects of chemotherapy, as the drug would be released only when the micro bubbles reach the cancerous part and the rest of the body wouldn’t be affected by the strong drugs.
If implemented, this could help many cancer patients to reduce the harmful effects of chemotherapy which ranges from hair loss to serious conditions. The micro bubbles may help turn cancer therapy into less invasive procedures.
“Because the drugs would only be released at the site of the diseased tissue, the patient’s total body exposure to them could be limited,” WorldPharmaNews said.
Availability and pricing is not yet available given that the Philips Research team is still working on the concept.